Barbara Vanderhyden

31PUBLICATIONS
131CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jan 29, 2026
Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.

Leonard Angka, Gayashan Tennakoon, David P Cook

|Nov 20, 2025
Cancer genetics and response to oncolytic virus treatment for ovarian cancer.

Erin L Fletcher, Alison O Cudmore, Barbara C Vanderhyden

|Mar 10, 2025
Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer.

Alison O Cudmore, Galaxia M Rodriguez, Vincent Maranda

|Aug 26, 2024
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

Sarah Spear, Olivia Le Saux, Hasan B Mirza

Pageof 6